Nuveen Portfolio holdings
Nuveen is the asset management arm of TIAA, a financial services group long focused on retirement savings for universities, other not-for-profit institutions and their employees. Nuveen manages all of TIAA's capital as well as money from outside investors, and began in Chicago in 1898 as John Nuveen & Company, an investment bank founded by John Nuveen Sr. to underwrite and sell municipal bonds. Its funds cover income, equity, real estate and real assets such as farmland and timberland, alongside private equity and private debt, and Nuveen and TIAA often invest their own money alongside clients. A private equity group led by Madison Dearborn Partners bought the firm in 2007, and it merged with TIAA in 2014.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$944M |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$593M |
| 3 |
Sandisk
SNDK
|
+$559M |
| 4 |
Booking.com
BKNG
|
+$521M |
| 5 |
Micron Technology
MU
|
+$516M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.07B |
| 2 |
Microsoft
MSFT
|
+$1.51B |
| 3 |
NVIDIA
NVDA
|
+$1.18B |
| 4 |
Apple
AAPL
|
+$1.04B |
| 5 |
Broadcom
AVGO
|
+$949M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.08% |
| 2 | Financials | 10.73% |
| 3 | Industrials | 10.3% |
| 4 | Consumer Discretionary | 9.56% |
| 5 | Healthcare | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2451
Corvus Pharmaceuticals
CRVS
$957M
| $2.42M | ﹤0.01% |
161,821
+12,695
| +9% | +$176K |
2025 Q2
4 quarters
|
|
2452
Brandywine Realty Trust
BDN
$553M
| $2.42M | ﹤0.01% |
762,333
+64,000
| +9% | +$192K |
2013 Q2
52 quarters
|
|
2453
Solid Biosciences
SLDB
$784M
| $2.41M | ﹤0.01% |
241,642
-158,650
| -40% | -$1.2M |
2024 Q2
8 quarters
|
|
2454
PennyMac Mortgage Investment
PMT
$698M
| $2.41M | ﹤0.01% |
213,825
-309,741
| -59% | -$3.41M |
2019 Q2
28 quarters
|
|
2455
Empire State Realty Trust
ESRT
$897M
| $2.41M | ﹤0.01% |
445,624
-476,274
| -52% | -$2.59M |
2019 Q1
29 quarters
|
|
2456
Kimco Realty Corp 7.25% Class N Preferred Stock
KIM.PRN
| $2.41M | ﹤0.01% |
39,354
-86
| -0.2% | -$5.28K |
2024 Q1
9 quarters
|
|
2457
Ovid Therapeutics
OVID
$557M
| $2.4M | ﹤0.01% |
+893,254
| New | +$2.3M |
2026 Q2
0 quarters
|
|
2458
Business First Bancshares
BFST
$1.06B
| $2.4M | ﹤0.01% |
78,000
+18,360
| +31% | +$519K |
2019 Q2
28 quarters
|
|
2459
Arbutus Biopharma
ABUS
$737M
| $2.38M | ﹤0.01% |
496,609
+237,592
| +92% | +$1.04M |
2021 Q2
20 quarters
|
|
2460
Zevra Therapeutics
ZVRA
$722M
| $2.38M | ﹤0.01% |
166,171
-26,417
| -14% | -$294K |
2023 Q2
12 quarters
|
|
2461
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$4.74B
| $2.38M | ﹤0.01% |
+19,997
| New | +$2.16M |
2026 Q2
0 quarters
|
|
2462
SunCoke Energy
SXC
$867M
| $2.38M | ﹤0.01% |
295,258
+114,324
| +63% | +$883K |
2017 Q1
37 quarters
|
|
2463
AMC Global Media
AMCX
$367M
| $2.38M | ﹤0.01% |
237,979
+171,138
| +256% | +$1.52M |
2013 Q2
52 quarters
|
|
2464
Pacira BioSciences
PCRX
$1.46B
| $2.37M | ﹤0.01% |
93,513
+3,707
| +4% | +$87.6K |
2019 Q2
28 quarters
|
|
2465
REalloys Inc
ALOY
$477M
| $2.37M | ﹤0.01% |
+164,034
| New | +$1.87M |
2026 Q2
0 quarters
|
|
2466
Tandem Diabetes Care
TNDM
$1.27B
| $2.37M | ﹤0.01% |
157,066
-206,736
| -57% | -$3.61M |
2019 Q2
28 quarters
|
|
2467
Horizon Bancorp
HBNC
$1.09B
| $2.37M | ﹤0.01% |
118,578
+12,399
| +12% | +$228K |
2019 Q2
28 quarters
|
|
2468
Cogent Communications
CCOI
$228M
| $2.36M | ﹤0.01% |
169,874
+1,374
| +0.8% | +$25.3K |
2019 Q2
28 quarters
|
|
2469
Del Monte Corp
DMC
$1.32B
| $2.36M | ﹤0.01% |
84,450
+3,757
| +5% | +$132K |
2019 Q2
28 quarters
|
|
2470
Coty
COTY
$3.72B
| $2.35M | ﹤0.01% |
1,087,044
+459,259
| +73% | +$991K |
2019 Q2
28 quarters
|
|
2471
Tenax Therapeutics
TENX
$81.1M
| $2.35M | ﹤0.01% |
+161,187
| New | +$2.06M |
2026 Q2
0 quarters
|
|
2472
Vanguard Morningstar Mid-Cap ETF
VO
$108B
| $2.34M | ﹤0.01% |
+29,100
| New | +$2.26M |
2026 Q2
0 quarters
|
|
2473
Maze Therapeutics
MAZE
$1.94B
| $2.34M | ﹤0.01% |
78,468
+15,108
| +24% | +$396K |
2025 Q1
5 quarters
|
|
2474
Avantis International Small Cap Value ETF
AVDV
$19.8B
| $2.34M | ﹤0.01% |
+22,705
| New | +$2.42M |
2026 Q2
0 quarters
|
|
2475
Capital Bancorp
CBNK
$699M
| $2.34M | ﹤0.01% |
66,563
+2,915
| +5% | +$93.4K |
2021 Q2
20 quarters
|
|
Similar funds
Nuveen's Q2 2026 Portfolio in Review
As of Q2 2026, Nuveen held 3,870 positions worth $419B, up 14% from $369B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Nuveen's Q2 2026 filing shows 648 new, 1,897 increased, 998 reduced and 136 closed positions. Its largest new stake was Honeywell Aerospace: 2,688,848 shares worth $594M. The largest sale was Amazon, an estimated $2.07B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.
- Nuveen's largest Q2 2026 buy was Honeywell Aerospace: 2,688,848 shares worth $594M.
- Nuveen added most to Tesla in Q2 2026, an estimated $944M increase.
- Nuveen's biggest Q2 2026 reduction was Amazon, cutting an estimated $2.07B.
- Nuveen fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2026, selling an estimated $393M.
- Nuveen's ten largest holdings make up 31% of its $419B portfolio in Q2 2026.
- Nuveen opened 648 new positions and closed 136 in Q2 2026.
- Nuveen's portfolio value rose 14% quarter-over-quarter to $419B.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.